"A Career in Biotech: Mistakes I've Made Along the Way"

December 2, 2015

Greg Licolai, M.D. '95
Greg Licholai, M.D. ’95, MBA, has more than 25 years of experience in biotechnology leadership, in both consulting and entrepreneurial capacities. He is president of Elpidera LLC, the third venture company formed by Moderna Therapeutics of Cambridge, Mass., and Stockholm, Sweden. Elpidera—whose name is derived from the Greek word for hope—is focused on the discovery of new therapies for rare diseases, using Moderna’s proprietary messenger RNA technology. His prior roles include those of senior vice president at Quintiles, partner-level consultant at McKinsey & Co., chief operating officer of Proteostasis, senior executive at Amicus Therapeutics, and co-founder of Immunome.
Loading the player...

Watch the presentation:

Medical school alumnus Greg Licholai talks about his decision, while a neurosurgical resident, to pursue an MBA and how that led him to his current role as president of Elpidera LLC.

alumni grand rounds at Yale School of Medicine

Alumni Grand Rounds is a series of talks that brings YSM alumni and students together for career-focused discussions about medicine and biomedical science, sponsored by the YSM Office of Development and Alumni Affairs.